Media Summary: "From Intern to Chief: A Tale of Partnerships and Persistence with a Vision for the Future," presented by In this expert Grand Rounds presentation, Topic: Advances in Molecular Based Therapy Speaker:

Dr Heather Wakelee Stanford Medicine - Detailed Analysis & Overview

"From Intern to Chief: A Tale of Partnerships and Persistence with a Vision for the Future," presented by In this expert Grand Rounds presentation, Topic: Advances in Molecular Based Therapy Speaker: Dr. Heather Wakelee on What to Do When Resistance to EGFR TKIs Emerges "Sex Differences in Lung Cancer" Heather Wakelee, MD

Photo Gallery

Dr. Heather Wakelee- Stanford Medicine
Dr. Heather Wakelee Discusses the AVAPERL Trial
Why I Went into Medicine, Heather Wakelee, MD
Frontiers in Oncology - Heather Wakelee, MD
Multi-Modality Immunotherapy for Resectable Lung Cancer | Dr. Heather Wakelee, Stanford Oncology
Dr. Heather Wakelee invites you to the 23rd Annual International Lung Cancer  Conference: July 28-30
Dr. Wakelee on Available Treatments Following Tumor Progression in Lung Cancer
Dr. Heather Wakelee Discusses Nintedanib Plus Chemotherapy in NSCLC
Lung Cancer Living Room™ - Advances in Molecular Based Therapy w/ Dr. Wakelee - 08/21/18 - Full 2-Hr
Dr. Wakelee Discusses Maintenance Therapy for Patients with Lung Cancer
Dr. Heather Wakelee on What to Do When Resistance to EGFR TKIs Emerges
Dr. Wakelee on Continued Maintenance in Lung Cancer
View Detailed Profile
Dr. Heather Wakelee- Stanford Medicine

Dr. Heather Wakelee- Stanford Medicine

Dr. Heather Wakelee- Stanford Medicine

Dr. Heather Wakelee Discusses the AVAPERL Trial

Dr. Heather Wakelee Discusses the AVAPERL Trial

Heather Wakelee

Why I Went into Medicine, Heather Wakelee, MD

Why I Went into Medicine, Heather Wakelee, MD

Thoracic Oncologist

Frontiers in Oncology - Heather Wakelee, MD

Frontiers in Oncology - Heather Wakelee, MD

"From Intern to Chief: A Tale of Partnerships and Persistence with a Vision for the Future," presented by

Multi-Modality Immunotherapy for Resectable Lung Cancer | Dr. Heather Wakelee, Stanford Oncology

Multi-Modality Immunotherapy for Resectable Lung Cancer | Dr. Heather Wakelee, Stanford Oncology

In this expert Grand Rounds presentation,

Dr. Heather Wakelee invites you to the 23rd Annual International Lung Cancer  Conference: July 28-30

Dr. Heather Wakelee invites you to the 23rd Annual International Lung Cancer Conference: July 28-30

Heather

Dr. Wakelee on Available Treatments Following Tumor Progression in Lung Cancer

Dr. Wakelee on Available Treatments Following Tumor Progression in Lung Cancer

Heather Wakelee

Dr. Heather Wakelee Discusses Nintedanib Plus Chemotherapy in NSCLC

Dr. Heather Wakelee Discusses Nintedanib Plus Chemotherapy in NSCLC

Heather Wakelee

Lung Cancer Living Room™ - Advances in Molecular Based Therapy w/ Dr. Wakelee - 08/21/18 - Full 2-Hr

Lung Cancer Living Room™ - Advances in Molecular Based Therapy w/ Dr. Wakelee - 08/21/18 - Full 2-Hr

Topic: Advances in Molecular Based Therapy Speaker:

Dr. Wakelee Discusses Maintenance Therapy for Patients with Lung Cancer

Dr. Wakelee Discusses Maintenance Therapy for Patients with Lung Cancer

Heather Wakelee

Dr. Heather Wakelee on What to Do When Resistance to EGFR TKIs Emerges

Dr. Heather Wakelee on What to Do When Resistance to EGFR TKIs Emerges

Dr. Heather Wakelee on What to Do When Resistance to EGFR TKIs Emerges

Dr. Wakelee on Continued Maintenance in Lung Cancer

Dr. Wakelee on Continued Maintenance in Lung Cancer

Heather Wakelee

Webinar FairLife November 2021 - Dr. Heather Wakelee IASLC

Webinar FairLife November 2021 - Dr. Heather Wakelee IASLC

Dr

"Sex Differences in Lung Cancer" Heather Wakelee, MD

"Sex Differences in Lung Cancer" Heather Wakelee, MD

"Sex Differences in Lung Cancer" Heather Wakelee, MD

Advances in Lung Cancer Treatment and Diagnosis from Stanford Health Care

Advances in Lung Cancer Treatment and Diagnosis from Stanford Health Care

Stanford

Dr. Heather Wakelee: Why Is It Important for You to Empower Lung Cancer Patients?

Dr. Heather Wakelee: Why Is It Important for You to Empower Lung Cancer Patients?

Expert

Molecular Profiling for Patients With Non-Small Cell Lung Cancer

Molecular Profiling for Patients With Non-Small Cell Lung Cancer

Heather Wakelee

Dr. Wakelee on the AVAPERL trial

Dr. Wakelee on the AVAPERL trial

Heather Wakelee

Dr. Heather Wakelee on "Which molecular marker tests do you seek?"

Dr. Heather Wakelee on "Which molecular marker tests do you seek?"

http://cancerGRACE.org/

A Hidden Health Disparity: Lung Cancer among Asian American Females Who Never Smoke

A Hidden Health Disparity: Lung Cancer among Asian American Females Who Never Smoke

Presented by The